Merck Boosts 2026 Sales Outlook on Strong Demand for New Drugs
Guidance·1 article across 1 outlet
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Merck & Co. boosted its 2026 sales outlook after strong demand for newer drugs like Winrevair helped to drive revenues higher in the second quarter.
The increase in sales forecast reflects the company's confidence in its product pipeline and market performance.
Merck
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Merck & Co. boosted its 2026 sales outlook after strong demand for newer drugs like Winrevair helped to drive revenues higher in the second quarter.”
Bloomberg — Merck Lifts 2026 Sales Forecast on Strength of Newer Drugs